The Patent Finder
VT

Vyne Therapeutics Inc.

First filing 2004
OverviewNotableFeesChangesFamiliesPatent listSources & methods

9 patents currently held

25 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
4 more records may belong here and await a decision; they are not counted.

The next term ends in Sep 2027. from the record

Of the 25 now held by other companies, 25 name Journey Medical Corporation as their current owner. Each row says so.

Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
8
Ending by 2030
Sep 2027
Next term end
4
Patent families

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
notable patents all others Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size.

Notable patents

Ranked by citations and family size, against patents of the same kind granted the same year. How we rank

Formerly held, still cited

Notable
Cited by 130 later US patents, top 5% of utility patents granted in 2018 in our data, and renewed at every maintenance window due so far. Protection runs to 2030. A terminal disclaimer caps this term to an earlier patent's.
Ends Oct 2030 · High confidence
Also notable
Cited by 126 later US patents, top 5% of utility patents granted in 2015 in our data, and renewed at every maintenance window due so far. Protection runs to 2028. A terminal disclaimer caps this term to an earlier patent's.
Ends Dec 2028 · High confidence

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Apr 27, 2027
    The maintenance fee for Non Surfactant Hydro-Alcoholic Foamable Compositions, Breakable Foams and Their Uses (US 9,167,813) comes due Apr 27, 2027. Unpaid by Oct 27, 2027, it lapses early.
  • 1 fee due Jun 15, 2027
    The maintenance fee for Antibiotic Kit and Composition and Uses Thereof (US 9,211,259) comes due Jun 15, 2027. Unpaid by Dec 15, 2027, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

  • 2 terms have ended since Aug 20, 2026

What they patent

Grouped by real patent family, largest first, labeled by the earliest filing in each. No technology classification is inferred from titles.

Patents held now

Soonest term end first.

Showing 1 to 9 of 9

PatentTitleStatusExpiresConfidence
US 7,700,076Penetrating Pharmaceutical Foam
In force
 · Low confidence
In forceLow confidence
US 10,117,812Foamable composition combining a polar solvent and a hydrophobic carrier
In force
 · Medium confidence
In forceMedium confidence
US 7,575,739Foamable Iodine Composition
In force
 · High confidence
In forceHigh confidence
US 9,265,725Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
In force
 · Medium confidence
In forceMedium confidence
US 7,820,145Oleaginous Pharmaceutical and Cosmetic Foam
In force
 · High confidence
In forceHigh confidence
US 9,211,259Antibiotic Kit and Composition and Uses Thereof
In force
 · Low confidence
In forceLow confidence
US 9,167,813Non Surfactant Hydro-Alcoholic Foamable Compositions, Breakable Foams and Their Uses
In force
 · High confidence
In forceHigh confidence
US 9,572,775Non Surfactant Hydro-Alcoholic Foamable Compositions, Breakable Foams And Their Uses
In force
 · High confidence
In forceHigh confidence
US 8,906,951Use of NK-1 Receptor Antagonists in Pruritus
In force
 · High confidence
In forceHigh confidence
Also on record, not counted in the 9: 25 patents in force now held by others · 71 patents ended · 1 application pending · 20 applications abandoned. List them

Sources and methods

Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited